iDNS3IP: Identification and Characterization of HCV NS3 Protease Inhibitory Peptides
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26115356 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Hui-Ju Kao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Research, Hsinchu MacKay Memorial Hospital, Hsinchu City 30071, Taiwan. Hauptthemen laut MEDLINE: Viral Nonstructural Proteins, Hepacivirus, Protease Inhibitors, Antiviral Agents. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council (NSTC), Taiwan, Hsinchu MacKay Memorial Hospital.
Abstract (Originalsprache)
Hepatitis C virus (HCV) infection remains a significant global health burden, driven by the emergence of drug-resistant strains and the limited efficacy of current antiviral therapies. A promising strategy for therapeutic intervention involves targeting the NS3 protease, a viral enzyme essential for replication. In this study, we present the first computational model specifically designed to identify NS3 protease inhibitory peptides (NS3IPs). Using amino acid composition (AAC) and K-spaced amino acid pair composition (CKSAAP) features, we developed machine learning classifiers based on support vector machine (SVM) and random forest (RF), achieving accuracies of 98.85% and 97.83%, respectively, validated through 5-fold cross-validation and independent testing. To support the accessibility of the strategy, we implemented a web-based tool, iDNS3IP, which enables real-time prediction of NS3IPs. In addition, we performed feature space analyses using PCA, t-SNE, and LDA based on AAindex descriptors. The resulting visualizations showed a distinguishable clustering between NS3IPs and non-inhibitory peptides, suggesting that inhibitory activity may correlate with characteristic physicochemical patterns. This study provides a reliable and interpretable platform to assist in the discovery of therapeutic peptides and supports continued research into peptide-based antiviral strategies for drug-resistant HCV. To enhance its flexibility, the iDNS3IP web tool also incorporates a BLAST-based similarity search function, enabling users to evaluate inhibitory candidates from both predictive and homology-based perspectives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Research, Hsinchu MacKay Memorial Hospital, Hsinchu City 30071, Taiwan.
- Department of Medical Research, Hsinchu Municipal MacKay Children's Hospital, Hsinchu City 30068, Taiwan.
- Department of Obstetrics and Gynecology, MacKay Memorial Hospital, Taipei City 10449, Taiwan.
- Department of Medicine, MacKay Medical College, New Taipei City 25245, Taiwan.
- Institute of Biomedical Sciences, MacKay Medical College, New Taipei City 25245, Taiwan.
- Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu City 30068, Taiwan.
ORCID-Profile: Hui-Ju Kao, Kai-Yao Huang
Förderung
- National Science and Technology Council (NSTC), Taiwan
- Hsinchu MacKay Memorial Hospital
Zitieren
APA
Kao, H. J., Weng, T. H., Chen, C. H., Yu, C. L., Chen, Y. C., Huang, C. C., Huang, K. Y., & Weng, S. L. (2025). iDNS3IP: Identification and Characterization of HCV NS3 Protease Inhibitory Peptides. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26115356
Vancouver
Kao HJ, Weng TH, Chen CH, Yu CL, Chen YC, Huang CC, et al. iDNS3IP: Identification and Characterization of HCV NS3 Protease Inhibitory Peptides. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26115356
BibTeX
@article{Kao2025,
author = {Kao, Hui-Ju and Weng, Tzu-Hsiang and Chen, Chia-Hung and Yu, Chen-Lin and Chen, Yu-Chi and Huang, Chen-Chen and Huang, Kai-Yao and Weng, Shun-Long},
title = {iDNS3IP: Identification and Characterization of HCV NS3 Protease Inhibitory Peptides},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26115356}
}
EUVIMED